AstraZeneca PLC’s Seroquel XR Gets EC Approval

September 3, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

LONDON (Reuters) - Drugmaker AstraZeneca (AZN.L) said on Thursday the European Commission had approved Seroquel XR as an add-on treatment for major depressive disorder for patients that had not responded well to an existing antidepressant

Twitter
LinkedIn
Facebook
Email
Print

FDA Approvals Europe

AstraZeneca Pharmaceuticals LP